CanSino Biologics, Inc. (CASBF)
4.90
+0.25
(+5.32%)
USD |
OTCM |
Oct 06, 16:00
CanSino Biologics Profit Margin (Quarterly) : 11.04% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.04% |
| March 31, 2026 | -21.24% |
| December 31, 2025 | 3.58% |
| September 30, 2025 | 9.00% |
| June 30, 2025 | -0.79% |
| March 31, 2025 | -8.42% |
| December 31, 2024 | -56.71% |
| September 30, 2024 | 1.12% |
| June 30, 2024 | -29.22% |
| March 31, 2024 | -153.0% |
| December 31, 2023 | -282.5% |
| September 30, 2023 | -115.4% |
| June 30, 2023 | |
| March 31, 2023 | -169.3% |
| December 31, 2022 | -145.5% |
| Date | Value |
|---|---|
| September 30, 2022 | -650.4% |
| June 30, 2022 | -75.33% |
| March 31, 2022 | 22.89% |
| December 31, 2021 | 47.22% |
| September 30, 2021 | 38.73% |
| June 30, 2021 | 59.75% |
| March 31, 2021 | -3.37% |
| December 31, 2020 | -1.15K% |
| September 30, 2020 | -4.48K% |
| June 30, 2020 | |
| March 31, 2020 | -573.3% |
| December 31, 2019 | -17.90K% |
| September 30, 2019 | -99.69K% |
| June 30, 2019 | -1.83K% |
| March 31, 2019 | -7.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.82% |
| Return on Assets | 0.56% |
| Return on Invested Capital | 0.64% |
| Gross Profit Margin (Quarterly) | 67.99% |
| Operating Margin (Quarterly) | 3.26% |
| Return on Net Operating Assets | 0.97% |